Drug

Regorafenib clinical trials

Also written Stivarga and BAY 73-4506.

studies test it: 198
open now: 39
in phase 3: 16
first study started: 2007

Keep track of what changes. Save the regorafenib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

198 studies that test it; most in 2014 (22)

Studies that test regorafenib, by start year
Year	Studies
2007	1
2008	1
2009	4
2010	4
2011	6
2012	1
2013	15
2014	22
2015	18
2016	16
2017	6
2018	9
2019	14
2020	11
2021	14
2022	12
2023	15
2024	11
2025	9
2026	9

By phase

A phase 1/2 study counts in both.

Phase 1: 62
Phase 2: 139
Phase 3: 16
Phase 4: 3
No phase: 5

What it is tested for

Each study’s main condition, where its own words name it.

Colorectal Neoplasms: 66
Carcinoma, Hepatocellular: 21
Neoplasms: 13
Gastrointestinal Stromal Tumors: 8
Rectal Neoplasms: 5
Colonic Neoplasms: 4
Glioblastoma: 4
Adenocarcinoma: 4
Melanoma: 3
Pancreatic Neoplasms: 3
Sarcoma, Ewing: 3
Sarcoma: 3

Who runs them

Industry 42 · Other 156

Bayer (32) · M.D. Anderson Cancer Center (6) · Tianjin Medical University Cancer Institute and Hospital (5) · Asan Medical Center (5) · City of Hope Medical Center (4) · Academic and Community Cancer Research United (4) · Memorial Sloan Kettering Cancer Center (4) · China Medical University, China (4)

Often tested with

Tested in the same studies.

Nivolumab (15) · Durvalumab (5) · Pembrolizumab (5) · Cadonilimab (5) · Trametinib (5) · Cabozantinib (5) · Capecitabine (4) · Irinotecan (4)

Studies

Open first, then newest update. How each study uses regorafenib is read from its arms, and is right about nine times in ten.

Testing it · 198

See all 198 studies that test regorafenib →

Given in every arm · 24 — regorafenib is usual care beside what is tested

Showing 20 of 24.

As the comparator · 27 — what is tested is compared with regorafenib

Showing 20 of 27.

Codes

What other systems call regorafenib · ClinicalTrials.gg INT005858

MeSH (NLM) C559147regorafenibConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) MGN125FS9DREGORAFENIBConfirmed FDA, Wikidata
RxNorm 1371319Confirmed FDA, Wikidata
Wikidata Q27137075regorafenib monohydrateConfirmed FDA, Wikidata
NCI Thesaurus C184955RegorafenibOne source FDA

System	Code	Name there	Checked by
MeSH (NLM)	C559147	regorafenib	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	MGN125FS9D	REGORAFENIB	Confirmed FDA, Wikidata
RxNorm	1371319	—	Confirmed FDA, Wikidata
Wikidata	Q27137075	regorafenib monohydrate	Confirmed FDA, Wikidata
NCI Thesaurus	C184955	Regorafenib	One source FDA

Also registered as regorafenib anhydrous (UNII 24T2A1DOYB · RxNorm 1312397).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.